Item 5.07. Submission of Matters to a Vote of Security Holders.

EyePoint Pharmaceuticals, Inc. (the "Company") held its 2020 Annual Meeting of Stockholders on June 23, 2020 via live webcast (the "Annual Meeting"). On April 24, 2020, the record date for the Annual Meeting, there were 124,741,832 shares of common stock of the Company (the "Common Stock") issued and outstanding and entitled to vote on the proposals presented at the Annual Meeting, of which 97,706,349 or 78.33%, were present in person or voted by proxy, which constituted a quorum. The holders of shares of its Common Stock are entitled to one vote for each share held and cumulative voting for directors is not permitted. The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows:

Proposal No. 1. Election of Directors

The Company's stockholders elected the following directors to the Board, each to serve until the Company's 2021 Annual Meeting or until such person's successor is duly elected and qualified. The voting on this proposal is set forth below:






                                         Vote Type   Vote Results
                 Göran Ando, M.D.        For           72,626,677
                                         Withheld       2,096,998
                                         Non Votes     22,982,674
                 Nancy Lurker            For           72,797,793
                                         Withheld       1,925,882
                                         Non Votes     22,982,674
                 Douglas Godshall        For           72,843,042
                                         Withheld       1,880,633
                                         Non Votes     22,982,674
                 Jay Duker, M.D.         For           72,716,324
                                         Withheld       2,007,351
                                         Non Votes     22,982,674
                 Kristine Peterson       For           64,647,704
                                         Withheld      10,075,971
                                         Non Votes     22,982,674
                 Ronald W. Eastman       For           72,625,644
                                         Withheld       2,098,031
                                         Non Votes     22,982,674
                 John B. Landis, Ph.D.   For           72,850,677
                                         Withheld       1,872,998
                                         Non Votes     22,982,674
                 David Guyer, M.D.       For           67,752,649
                                         Withheld       6,971,026
                                         Non Votes     22,982,674
                 Wendy F. DiCicco        For           72,903,712
                                         Withheld       1,819,963
                                         Non Votes     22,982,674

Proposal No. 2. Approval of Amendment to the Certification of Incorporation

The Company's stockholders approved the adoption of an amendment to the Company's Certificate of Incorporation to increase the number of shares of Common Stock that are authorized for issuance from 150,000,000 shares to 300,000,000 shares. The voting on this proposal is set forth below:






                            Vote type   Vote Results
                            For          88,133,505
                            Against       8,590,975
                            Abstain         981,869
                            Non Votes             0

--------------------------------------------------------------------------------

Proposal No. 3. Non-Binding Advisory Vote on Named Executive Officer Compensation

The Company's stockholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. The voting on this proposal is set forth below:






                            Vote type   Vote Results
                            For          63,788,233
                            Against      10,393,776
                            Abstain         541,666
                            Non Votes    22,982,674


Proposal No. 4.  Ratification of Appointment of Independent Registered Public
Accounting Firm

The Company's stockholders ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2020. The voting on this proposal is set forth below:






                            Vote type   Vote Results
                            For          96,186,362
                            Against         934,990
                            Abstain         584,997
                            Non Votes             0


Item 9.01  Financial Statements and Exhibits


(d) Exhibits.




Exhibit No.       Description

3.1                 Certificate of Amendment of the Certificate of Incorporation of
                  Eyepoint Pharmaceuticals, Inc  .

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses